Hormone News and Research RSS Feed - Hormone News and Research

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. It is essentially a chemical messenger that transports a signal from one cell to another.
Low intake of dietary salt could be dangerous

Low intake of dietary salt could be dangerous

Findings from a large, four-year study suggest that an inadequate amount of salt in the diet could increase the risk of poor cardiovascular outcomes and death. [More]
Even with no explicit memory of childhood trauma, PTSD can develop in adulthood

Even with no explicit memory of childhood trauma, PTSD can develop in adulthood

There are many forms of memory and only some of these may be critical for the development of posttraumatic stress disorder (PTSD), reports a new study by researchers at the University at Albany and the University of California Los Angeles. [More]
Recurrence of breast cancer cut by ½ in overweight women who regularly use NSAIDs

Recurrence of breast cancer cut by ½ in overweight women who regularly use NSAIDs

Recurrence of hormone-related breast cancer was cut by half in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), according to data published in Cancer Research, a journal of the American Association for Cancer Research. [More]
Scientists identify gene that regulates sleep and wake rhythms

Scientists identify gene that regulates sleep and wake rhythms

Scientists at the Salk Institute for Biological Studies have identified a gene that regulates sleep and wake rhythms. [More]
Tarsa obtains $10 million senior credit facility to support NDA submission for Ostora tablet

Tarsa obtains $10 million senior credit facility to support NDA submission for Ostora tablet

Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015. [More]
Experts to debate healthy labor and delivery practices at Cedars-Sinai Birth Community Day

Experts to debate healthy labor and delivery practices at Cedars-Sinai Birth Community Day

Doctors, nurses, midwives and doulas will debate healthy labor and delivery practices - including the use of the synthetic hormone Pitocin to hasten childbirth and vitamin K to speed blood clotting in newborns -- at the third annual Cedars-Sinai Birth Community Day, Aug. 14. [More]
Blood expression levels of genes targeted by stress hormones could be biomarker for developing PTSD

Blood expression levels of genes targeted by stress hormones could be biomarker for developing PTSD

Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD), according to a study conducted in rats by researchers at the Icahn School of Medicine at Mount Sinai and published August 11 in Proceedings of the National Academy of Sciences (PNAS). [More]
Researchers find new ways to treat hormone receptor-positive breast cancer

Researchers find new ways to treat hormone receptor-positive breast cancer

A leading scientist based at Keele University in North Staffordshire has been awarded a grant of around £20,000 by research charity Breast Cancer Campaign to find new ways to treat hormone receptor-positive breast cancer, the most common type of the disease. [More]
Cochrane review finds little evidence to support use of sleep or wake drugs for shift workers

Cochrane review finds little evidence to support use of sleep or wake drugs for shift workers

Shift workers are taking drugs to help them stay awake or get to sleep despite weak evidence for their benefit, according to a new Cochrane review. [More]
Researchers discover how arginine starvation specifically kills cancer cells

Researchers discover how arginine starvation specifically kills cancer cells

Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells. [More]
Study: Effects of testosterone on brain's response to threat cues in healthy men

Study: Effects of testosterone on brain's response to threat cues in healthy men

A new study in Biological Psychiatry reports on a neural circuit for male aggression. Testosterone, a steroid hormone, is well known to contribute to aggressive behavior in males, but the neural circuits through which testosterone exerts these effects have not been clear. [More]
Acidity sensor helps to estimate dynamics of insulin production

Acidity sensor helps to estimate dynamics of insulin production

Many human metabolic functions only run smoothly if the acid level in the body remains neutral and stable. For humans, normal blood pH values lie between 7.35 and 7.45. By way of comparison, an empty stomach is extremely acidic, with a pH value of 1.5. [More]
UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

The University of Chicago Medicine and Advocate Children's Hospital / Advocate Health Care have received a five-year, $1.8-million grant from the National Institutes of Health to find new ways to delay and prevent type 1 diabetes. The grant will establish the first Type 1 Diabetes TrialNet Clinical Center in Chicago. [More]
Research sheds light on role of hepatic mTORC1 in whole body physiology

Research sheds light on role of hepatic mTORC1 in whole body physiology

The protein mTOR is a central controller of growth and metabolism. Deregulation of mTOR signaling increases the risk of developing metabolic diseases such as diabetes, obesity and cancer. [More]
Inovio Pharmaceuticals reports increased revenue in second quarter 2014

Inovio Pharmaceuticals reports increased revenue in second quarter 2014

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013. [More]

Research reveals that 59% of wines contain significant quantities of phthalate, dibutyl phthalate

Why alcohol may be even more damaging to your health then you first thought. We all know what risks our favourite wines and spirits pose to our health but now scientists reveal that the packaging of these drinks may be just as damaging. Is it time to leave that extra bottle of red on the supermarket shelf? [More]
University of Chicago adds six new members to governing Board of Trustees

University of Chicago adds six new members to governing Board of Trustees

The University of Chicago Medical Center added six new members to its governing Board of Trustees, and named a new president of the medical staff. [More]
High levels of pervasive chemical in women may lead to adverse effects in offspring

High levels of pervasive chemical in women may lead to adverse effects in offspring

In some women abnormally high levels of a common and pervasive chemical may lead to adverse effects in their offspring. [More]
Whey protein drink can control erratic glucose levels associated with type 2 diabetes

Whey protein drink can control erratic glucose levels associated with type 2 diabetes

Blood sugar surges - after-meal glucose "spikes" - can be life threatening for the 29 million Americans with diabetes. Diabetic blood sugar spikes have been linked to cardiovascular disease, cancer, Alzheimer's disease, kidney failure, and retinal damage. [More]
Aeterna Zentaris signs strategic co-promotion services agreement with ASCEND

Aeterna Zentaris signs strategic co-promotion services agreement with ASCEND

Aeterna Zentaris Inc. today announced a strategic co-promotion services agreement with ASCEND Therapeutics US, LLC. [More]